COVID-19 vaccine maker Novavax is looking to do more clinical trials in Australia, including further research to develop its combined coronavirus and influenza vaccine.the strength of Australia’s medical research sector has been a significant drawcard for the company.
“We find this a very appealing place to do work — it is very sophisticated, the medical infrastructure is very good, and the regulatory and political structures are favourable,” he said.market and has already undertaken a range of research projects here.Dubovsky said the company was “agnostic” about the locations and partners it could use in future, saying Novavax had done work in Victoria, New South Wales and Queensland but was open to other sites.
Dubovsky would not comment on whether Novavax’s product was more advanced in its development than Moderna’s at this stage, but said the industry was moving towards developing vaccines that target more than one respiratory virus at a time. Current booster uptake figures around the world suggest that “people are getting tired of having to get re-vaccinated”, he said.
MsEmmaK HAHAHAHAHAHAHA There will be no vaccine industry after Nuremberg2 You will be lucky to survive it too, Fake News.
MsEmmaK “the regulatory and political structures are favourable” … 🤔. That’s a worry and says a lot.
MsEmmaK
MsEmmaK
MsEmmaK Australia please say NO